Advertisement

 

 

Evaluation of a minimally invasive glucose biosensor for continuous tissue monitoring.

Evaluation of a minimally invasive glucose biosensor for continuous tissue monitoring.
Author Information (click to view)

Sharma S, Huang Z, Rogers M, Boutelle M, Cass AE,


Sharma S, Huang Z, Rogers M, Boutelle M, Cass AE, (click to view)

Sharma S, Huang Z, Rogers M, Boutelle M, Cass AE,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

Analytical and bioanalytical chemistry 2016 Oct 15()
Abstract

We describe here a minimally invasive glucose biosensor based on a microneedle array electrode fabricated from an epoxy-based negative photoresist (SU8 50) and designed for continuous measurement in the dermal compartment with minimal pain. These minimally invasive, continuous monitoring sensor devices (MICoMS) were produced by casting the structures in SU8 50, crosslinking and then metallising them with platinum or silver to obtain the working and reference electrodes, respectively. The metallised microneedle array electrodes were subsequently functionalised by entrapping glucose oxidase in electropolymerised polyphenol (PP) film. Sensor performance in vitro showed that glucose concentrations down to 0.5 mM could be measured with a response times (T90) of 15 s. The effect of sterilisation by Co60 irradiation was evaluated. In preparation for further clinical studies, these sensors were tested in vivo in a healthy volunteer for a period of 3-6 h. The sensor currents were compared against point measurements obtained with a commercial capillary blood glucometer. The epoxy MICoMS devices showed currents values that could be correlated with these. Graphical Abstract Microneedle arrays for continuous glucose monitoring in dermal interstitial fluid.

Submit a Comment

Your email address will not be published. Required fields are marked *

5 × 5 =

[ HIDE/SHOW ]